Rituxan Safety Questions, Rituxan Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Rituxan side effects. Check out Health Surveys and Health Polls. If you have questions about Rituxan, you can post them to our Doctors or Ask Patient Community about Rituxan.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Rituxan
Rituxan Safety Reports
Total Rituxan reports: 848.Rituxan FDA safety alerts: 2004 2006 .
Reported deaths: 139 Reported hospitalizations: 371.
Take Rituxan Side Effects Survey or Share Your Rituxan Story.
Reported Rituxan Side Effects: pyrexia, infusion related reaction, neutropenia, chills, pneumocystis jiroveci pneumonia, hypotension, dyspnoea, renal failure acute, dyspnoea exertional, progressive multifocal leukoencephalopathy, condition aggravated.
Rituxan Usage.
< Previous Showing 101-150 of 848 Next >
Rituxan Side Effects Report #5269184-XPhysician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient, 43 years of age, weighting 142.0 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: complication of pregnancy. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with EFFEXOR, XANAX, GABAPENTIN. Patient recovered.
Rituxan Side Effects Report #5269450-8
RITUXAN problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.
Rituxan Side Effects Report #5269460-0
Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.
Rituxan Side Effects Report #5269461-2
RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5269463-6
Physician from JAPAN reported RITUXAN problem on Mar 06, 2007. Female patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. RITUXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, CYTARABINE, CISPLATIN. Patient recovered.
Rituxan Side Effects Report #5269571-X
RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5269651-9
Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.
Rituxan Side Effects Report #5269662-3
RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, obstruction gastric, pancreatic disorder. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5269951-2
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 01, 2007. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abnormal faeces, chest discomfort, fatigue, international normalised ratio increased, platelet count decreased. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5270544-1
RITUXAN problem was reported by a Pharmacist from UNITED STATES on Mar 10, 2007. Female patient, 27 years of age, was diagnosed with central nervous system lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bradycardia. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5273346-5
Physician from JAPAN reported RITUXAN problem on Mar 06, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma recurrent, bile duct cancer. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5273347-7
RITUXAN problem was reported by a Physician from JAPAN on Mar 04, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric ulcer, gastrointestinal haemorrhage, helicobacter infection, hepatic failure, tumour lysis syndrome. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.
Rituxan Side Effects Report #5273404-5
Physician from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHASPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5273406-9
RITUXAN problem was reported by a Physician from UNITED KINGDOM on Mar 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: atelectasis, c-reactive protein increased, chest pain, haemoglobin decreased, hypoxia, lymphocyte count decreased, neutrophil count decreased, pericardial rub, pleuritic pain. RITUXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, FOLIC ACID, ALENDRONATE, CALCICHEW DE, AMITRIPRYLINE, KETOPROFEN. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5273407-0
Physician from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5273597-X
RITUXAN problem was reported by a Health Professional from NORWAY on Mar 07, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5273599-3
Health Professional from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5273603-2
RITUXAN problem was reported by a Pharmacist from JAPAN on Mar 07, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5273616-0
Health Professional from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5274442-9
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 06, 2007. Female patient, 84 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, bone marrow failure. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PANTOPRAZOLE, AMLODIPINE BESYLATE, CLONAZEPAM, ACYCLOVIR. Patient recovered.
Rituxan Side Effects Report #5274443-0
Physician from UNITED STATES reported RITUXAN problem on Mar 09, 2007. Female patient, 65 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. RITUXAN dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5277897-9
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 67 years of age, weighting 134.9 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gallbladder operation. RITUXAN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5278423-0
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Feb 20, 2007. Female patient, 59 years of age, weighting 131.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: air-borne transmission. RITUXAN dosage: unknown. During the same period patient was treated with PREMPRO, OXYCONTIN, FOLIC ACID, OXYCODONE, WELLBUTRIN, EFFEXOR, CYMBALTA, NEURONTIN. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5278426-6
RITUXAN problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Female patient, 72 years of age, weighting 226.4 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood glucose increased, coronary artery occlusion. RITUXAN dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with ALTACE, TOPROL, NORVASC, METHOTREXATE, FOLATE, GLIPIZIDE, METFORMIN, LIPITOR. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5278712-X
Physician from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5281326-9
RITUXAN problem was reported by a Physician from GERMANY on Mar 13, 2007. Male patient, child 2 years of age, weighting 4.41 lb, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: herpes sepsis, herpes zoster, hypogammaglobulinaemia, intestinal functional disorder, lung disorder, meningeal disorder, pneumonia parainfluenzae viral. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, DAPSONE. Patient recovered.
Rituxan Side Effects Report #5281327-0
Health Professional from GERMANY reported RITUXAN problem on Mar 13, 2007. Female patient, 81 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumonia bacterial, pulmonary embolism. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. Patient recovered.
Rituxan Side Effects Report #5281329-4
RITUXAN problem was reported by a Health Professional from GERMANY on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastroenteritis clostridial, intestinal functional disorder, pneumonia. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5281340-3
Pharmacist from UNITED STATES reported RITUXAN problem on Mar 23, 2007. Female patient, weighting 118.6 lb, was diagnosed with graft thrombosis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, air embolism, arteriosclerosis coronary artery, chest pain, infusion related reaction, pericardial effusion, pleural effusion, sepsis syndrome, shock. RITUXAN dosage: 33.3 MG ONCE IV DRIP. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized and became disabled. Patient recovered.
Rituxan Side Effects Report #5281829-7
RITUXAN problem was reported by a Health Professional from GERMANY on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, pneumonia bacterial. RITUXAN dosage: 375 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient died.
Rituxan Side Effects Report #5282463-5
Physician from UNITED STATES reported RITUXAN problem on Mar 14, 2007. Female patient, 55 years of age, was diagnosed with dermatomyositis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia. RITUXAN dosage: 1000 MG, INTRAVENOUS. Patient died on 03/10/2007.
Rituxan Side Effects Report #5282464-7
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Male patient, 67 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, ejection fraction decreased, fluid retention, palpitations, weight increased. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE, DEXAMETHASONE, CYTARABINE, LEUCOVORIN CALCIUM, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.
Rituxan Side Effects Report #5282465-9
Health Professional from UNITED STATES reported RITUXAN problem on Mar 13, 2007. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, METHOTREXATE, PRILOSEC, ZYRTEC, ACTONEL, LORTAB, ULTRAM, CELEBREX. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5283160-2
RITUXAN problem was reported by a Physician from CANADA on Mar 14, 2007. Female patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, lung disorder. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5284952-6
Physician from JAPAN reported RITUXAN problem on Mar 15, 2007. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: prepyloric stenosis. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5285235-0
RITUXAN problem was reported by a Physician from CANADA on Mar 19, 2007. Female patient, 59 years of age, weighting 143.3 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, neutropenia. RITUXAN dosage: 375 MG/M2, UNK; INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5286106-6
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 20, 2007. Female patient, 71 years of age, weighting 162.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, surgery. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5286108-X
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 23, 2007. Female patient, 40 years of age, was diagnosed with systemic lupus erythematosus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, DURAGESIC, FOSAMAX, ZOFRAN, NORTRIPTYLIN. Patient recovered.
Rituxan Side Effects Report #5286109-1
Physician from UNITED STATES reported RITUXAN problem on Mar 19, 2007. Male patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, PROTONIX, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5286911-6
RITUXAN problem was reported by a Physician from CANADA on Mar 20, 2007. Male patient, 84 years of age, weighting 134.5 lb, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anuria, chills, hypotension. RITUXAN dosage: 640 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5286922-0
Physician from JAPAN reported RITUXAN problem on Mar 23, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: peritonitis. RITUXAN dosage: 570 MG, SINGLE; INTRAVENOUS, 560 MG, SINGLE; INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, PARAPLATIN, ETOPOSIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5288251-8
RITUXAN problem was reported by a Physician from JAPAN on Mar 19, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, diffuse large b-cell lymphoma recurrent. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5288254-3
Health Professional from RUSSIAN FEDERATION reported RITUXAN problem on Mar 23, 2007. Male patient, 72 years of age, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cavernous sinus thrombosis, sinusitis. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, AMOXICLAV. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5203831-3
RITUXAN problem was reported by a Physician from UNITED STATES on Dec 27, 2006. Female patient, 28 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, pre-eclampsia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.
Rituxan Side Effects Report #5205207-1
Physician from JAPAN reported RITUXAN problem on Dec 27, 2006. Female patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, gait disturbance, joint swelling, osteonecrosis. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADIRACIN, ONCOVIN, PREDNISOLONE, VEPESID. Patient recovered.
Rituxan Side Effects Report #5269450-8
RITUXAN problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.
Rituxan Side Effects Report #5269460-0
Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.
Rituxan Side Effects Report #5269461-2
RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5269571-X
Physician from JAPAN reported RITUXAN problem on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Rituxan Side Effects Report #5269651-9
RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.
< Previous Showing 101-150 of 848 Next >
Drug Information: Rituximab Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607038.html
ri tux' i mabIMPORTANT WARNING:
| Some people who received rituximab experienced severe reactions to the medication. Some of these people died within 24 hours after they received a dose of rituximab. Most of these deaths happened after the first dose of rituximab. Tell your doctor if you have or have ever had chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells), mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system), an irregular heartbeat, or heart or lung disease. If you have any of these conditions, or if you are female, there is a greater chance that you will experience a serious reaction to rituximab. If you experience any of the following symptoms, tell your doctor or other health care provider immediately: hives; swelling of the lips, tongue, or throat; difficulty breathing or swallowing; dizziness; fainting; shortness of breath, wheezing; blurred vision; headache; pounding or irregular heartbeat; fast or weak pulse; loss of consciousness, fast breathing; pale or bluish skin; pain in the chest that may spread to other parts of the upper body; weakness; excessive tiredness; sweating; or anxiety.When rituximab is used to treat non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fight infection) it may cause a condition called tumor lysis syndrome (TLS; a group of symptoms caused by the fast breakdown of cancer cells). TLS may cause kidney failure and the need for dialysis treatment. Tell your doctor if you are also receiving cisplatin (Platinol). If you notice that you need to urinate less often than usual or that you produce less urine than usual, tell your doctor immediately.Rituximab has caused severe skin reactions. These reactions have caused death. If you experience any of the following symptoms, tell your doctor immediately: painful sores, ulcers, blisters, rash, or peeling skin.Some people who received rituximab developed progressive multifocal leukoencephalopathy (PML; a rare infection of the brain that cannot be treated, prevented, or cured and that usually causes death or severe disability) during or after their treatment. If you experience any of the following symptoms, call your doctor immediately: difficulty thinking clearly or walking, loss of strength, vision problems, or any other unusual symptoms that develop suddenly.Talk to your doctor about the risks of using rituximab. |
Why is this medication prescribed?
Rituximab is used alone or with other medications to treat certain types of non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fights infection). Rituximab is also used with another medication to treat the symptoms of rheumatoid arthritis (RA; a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in people who have already been treated with a certain type of medication called a tumor necrosis factor (TNF) inhibitor. Rituximab is in a class of medications called biologic antineoplastic agents.It treats NHL by causing the death of blood cells that have multiplied abnormally. It treats rheumatoid arthritis by causing the death of certain blood cells that may cause the immune system to attack the joints.
How should this medicine be used?
Rituximab comes as a solution (liquid) to be injected into a vein. Rituximab is administered by a doctor or nurse in a medical office or infusion center. When rituximab is used to treat rheumatoid arthritis, it is usually given as 2 doses spaced 2 weeks apart. When rituximab is used to treat NHL it is either given once a week for 4-8 weeks or on the first day of each chemotherapy cycle. Your dosing schedule will depend on the condition that you have, the other medications you are using, and how well your body responds to treatment.
Rituximab must be given slowly. It may take several hours or longer to receive your first dose of rituximab, so you should plan to spend most of the day at the medical office or infusion center. After the first dose, you may receive your medication more quickly, depending on how you respond to treatment.
You may experience symptoms such as fever, shaking chills, tiredness, headache, or nausea while you are receiving a dose of rituximab, especially the first dose. Tell your doctor or other healthcare provider if you experience these symptoms while you are receiving your medication. Your doctor may prescribe other medications to help prevent or relieve these symptoms. Your doctor may tell you to take these medications before you receive each dose of rituximab.
Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using rituximab,
- tell your doctor and pharmacist if you are allergic to rituximab or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medication in the IMPORTANT WARNING section and either of the following: medications for high blood pressure and other medications for rheumatoid arthritis. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have any of the conditions mentioned in the IMPORTANT WARNING section and if you have or have ever had hepatitis B or other viruses such as chicken pox, herpes (a virus that may cause cold sores or outbreaks of blisters in the genital area), West Nile virus (a virus that is spread through mosquito bites and may cause serious symptoms), or cytomegalovirus (a common virus that usually only causes serious symptoms in people who have weakend immune systems or who are infected at birth). Also tell your doctor if you have any type of infection now or if you have or have ever had an infection that would not go away or an infection that comes and goes.
- tell your doctor if you are pregnant or plan to become pregnant. Rituximab may harm the fetus. You should use birth control to prevent pregnancy during your treatment with rituximab and for up to 12 months after your treatment. Talk to your doctor about types of birth control that will work for you. If you become pregnant while using rituximab, call your doctor.
- tell your doctor if you are breast-feeding.You should not breast-feed during your treatment with rituximab or for some time after your treatment
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are using rituximab.
- you should know that you may be drowsy or dizzy after you receive a dose of rituximab. Do not drive a car or operate machinery until you know how this medication affects you. Plan to have someone else drive you home from the medical office or infusion center after you receive your treatment.
- ask your doctor whether you should receive any vaccinations before you begin your treatment with rituximab. Do not have any vaccinations during your treatment without talking to your doctor.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
If you miss an appointment to receive rituximab, call your doctor right away.
What side effects can this medication cause?
Rituximab may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- nausea
- vomiting
- diarrhea
- heartburn
- weight gain
- muscle or back pain
- flushing
- night sweats
- tiredness
- weakness
- numbness, burning or tingling in the hands or feet
- runny nose
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- stomach area pain
- unusual bruising or bleeding
- sore throat, fever, chills, or other signs of infection
- chest tightness
- joint pain or soreness
Rituximab may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to rituximab.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|